Seroquel

Thursday, 04 November 2021

Latest News for: seroquel

Edit

Luye Pharma Becomes the Marketing Authorization Holder for Seroquel and Seroquel XR in Saudi Arabia

MENA FN 20 Sep 2021

(MENAFN - Mid-East.Info) Jeddah, Saudi Arabia. Luye Pharma Group has recently been granted official approval by the Saudi Food and Drug Authority to become the Marketing Authorization Holder (MAH) ... .

Edit

Luye Pharma Becomes the Marketing Authorization Holder for Seroquel and Seroquel XR in Saudi Arabia (Luye Pharma Group Ltd)

Public Technologies 18 Sep 2021

Luye Pharma Group has recently been granted official approval by the Saudi Food and Drug Authority to become the Marketing Authorization Holder (MAH) for Seroquel and Seroquel XR in Saudi Arabia ... Seroquel and Seroquel XR are two of Luye Pharma's key Central Nervous System (CNS) ...

Edit

[2010] psychiatrist Stefan Kruszewski - whistleblower on AstraZeneca's "Seroquel" exaggerations

Bitchute 13 Jul 2021

Go to the source via the link below to view the video ....

Edit

Luye Pharma Signs Two Agreements in Latin America, Global Business System for Seroquel Continues to ...

MENA FN 11 Sep 2020

(MENAFN - PR Newswire) SHANGHAI, Sept. 11, 2020 /PRNewswire/ -- Luye Pharma Group recently signed two agreements with partners in Latin America, boost... .

Edit

Luye Pharma Signs Two Agreements in Latin America, Global Business System for Seroquel Continues to Grow Rapidly

PR Newswire 11 Sep 2020

Seroquel® and Seroquel XR® are atypical anti-psychotic (AAP) medicines with antidepressant properties. The main indications for Seroquel are the treatment of schizophrenia and bipolar disorder. Seroquel XR® is also approved in some markets for major depressive disorder and generalized anxiety disorder.

Edit

VOLUNTARY ANNOUNCEMENT - LUYE GRANTED EXCLUSIVE DISTRIBUTION AND MARKETING RIGHTS IN SOUTH KOREA FOR SEROQUEL AND SEROQUEL XR TO ALVOGEN

Public Technologies 20 May 2020

SOUTH KOREA FOR SEROQUEL® AND SEROQUEL XR® TO ALVOGEN ... (''Alvogen'') for Seroquel® and Seroquel XR® in South Korea. Seroquel® (quetiapine fumarate, immediate release, IR) and Seroquel XR® (extended release formulation) are atypical anti-psychotic (AAP) medicines with antidepressant properties.

Edit

VOLUNTARY ANNOUNCEMENT - LUYE GRANTED MOKSHA8 THE EXCLUSIVE PROMOTION RIGHTS IN BRAZIL AND MEXICO FOR SEROQUEL

Public Technologies 13 May 2020

IN BRAZIL AND MEXICO FOR SEROQUEL® ... de C.V., two subsidiaries of Moksha8 Pharmaceuticals (''Moksha8''), for Seroquel® and Seroquel XR® in Brazil and Mexico. Seroquel® (quetiapine fumarate, immediate release, IR) and Seroquel XR® (extended release formulation) are atypical anti-psychotic (AAP) medicines with antidepressant properties.

Edit

Seroquel Market Analysis 2018 by Share Latest Trends, Leading Global Key Players, Future Growth, Revenue, ...

MENA FN 11 Apr 2020

(MENAFN - America News Hour) Kenneth Research has recently published a report on the Global and Southeast Asia Seroquel Market which is anticipated to... .

Edit

Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries

PR Newswire 11 Feb 2020

10, 2020 /PRNewswire/ -- Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), for Seroquel® and Seroquel XR® in South Africa, Namibia and Botswana.

Edit

Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel� and Seroquel XR� ...

The Record 11 Feb 2020

10, 2020 /PRNewswire/ -- Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), for Seroquel� and Seroquel XR� in South Africa, Namibia and Botswana.

Edit

Agreement with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia completed

Public Technologies 16 Dec 2019

In the year to 31 December 2018, the aggregate profit before tax attributable to Seroquel and Seroquel XR in the relevant territories was $86m ... Seroquel and Seroquel XR are atypical anti-psychotic medicines with antidepressant properties.

Edit

Seroquel rights agreement complete: Europe, Russia

Public Technologies 16 Dec 2019

Agreement with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia completed ... In the year to 31 December 2018, the aggregate profit before tax attributable to Seroquel and Seroquel XR in the relevant territories was $86m ... Seroquel and Seroquel XR are atypical anti-psychotic medicines with antidepressant properties.

Edit

AstraZeneca divests rights to Seroquel and Seroquel XR in the US and Canada

Public Technologies 03 Dec 2019

Seroquel and Seroquel XR, used primarily to treat schizophrenia and bipolar disorder, have lost their compound patent protection in the US and Canada ... AstraZeneca will continue to manufacture and supply Seroquel and Seroquel XR to Cheplapharm during a transition period.

Edit

AstraZeneca divests Seroquel rights: US and Canada

Public Technologies 03 Dec 2019

Cheplapharm recently agreed to acquire the commercial rights to Seroquel and Seroquel XR in most European markets and Russia from AstraZeneca and this new agreement will ... About Seroquel Seroquel and Seroquel XR are atypical anti-psychotic medicines with antidepressant properties.

Edit

AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia

Public Technologies 30 Oct 2019

Seroquel and Seroquel XR, used primarily to treat schizophrenia and bipolar disorder, have lost their compound patent protection in Europe and Russia ... AstraZeneca will continue to manufacture and supply Seroquel and Seroquel XR to Cheplapharm during a transition period.